Pertento entities, Eduardo Marques list holdings in Nutex Health (NUTX) on 13G/A

Rhea-AI Filing Summary

Nutex Health, Inc. ownership amendment reports that Pertento-related entities and Eduardo Marques each hold notable common stock positions. Pertento Partners LLP, Pertento Advisors LLC, and Eduardo Marques are listed with 405,029 shares (5.9%) each; Pertento Master Fund Limited holds 361,201 shares (5.3%). The filing is an amendment to a Schedule 13G/A with CUSIP 67079U306, dated 05/01/2026 and signed 05/07/2026.

Key Figures

Filing date: 05/01/2026 Signature date: 05/07/2026 Pertento Partners LLP holdings: 405,029 shares +5 more

8 metrics

Filing date 05/01/2026 document date shown on cover

Signature date 05/07/2026 dates on signature block for Eduardo Marques

Pertento Partners LLP holdings 405,029 shares Amount beneficially owned as reported

Pertento Advisors LLC holdings 405,029 shares Amount beneficially owned as reported

Pertento Master Fund Limited holdings 361,201 shares Amount beneficially owned as reported

Eduardo Marques holdings 405,029 shares Amount beneficially owned as reported

Percent of class (example) 5.9% Percent of class reported for Pertento Partners/Advisors/Marques

Percent of class (master fund) 5.3% Percent of class reported for Pertento Master Fund Limited

Key Terms

Schedule 13G/A, Beneficially owned, Joint Filing Agreement, CUSIP 67079U306

4 terms

Schedule 13G/A regulatory

"Item 1. | (a) | Name of issuer: Nutex Health, Inc."

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned regulatory

"Item 4. | Ownership (a) | Amount beneficially owned: Pertento Partners LLP - 405,029"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Joint Filing Agreement legal

"Exhibit A - Joint Filing Agreement"

CUSIP 67079U306 market

"Title of class of securities: Common Stock, $0.001 par value (e) | CUSIP No.: 67079U306"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/07/2026 - 04:15 PM Learn about SEC filing dates

FAQ

What ownership does Pertento report in Nutex Health (NUTX)?

Pertento reports 405,029 shares (5.9%) by Pertento Partners LLP and Pertento Advisors LLC. The amendment also lists Pertento Master Fund Limited with 361,201 shares (5.3%), and Eduardo Marques with 405,029 shares (5.9%) as shown in the filing.

When was the Schedule 13G/A amendment for NUTX filed and signed?

The amendment shows a document date of 05/01/2026 and signatures dated 05/07/2026. Those dates appear on the cover and signature block of the filing and identify when the reporting persons certified the amendment.

Who signed the Nutex Health 13G/A amendment?

Eduardo Marques signed for each reporting person in multiple capacities: Managing Partner and Authorized Person. The signature block lists Marques and the date 05/07/2026 for each signature entry.

What CUSIP and class of security are covered in the NUTX amendment?

The filing covers Common Stock, $0.001 par value, CUSIP 67079U306. The class and CUSIP are stated in Item 1 and Item 4 of the amendment as the security reported.

Do the reporting persons claim beneficial ownership for all listed shares?

The reporting persons disclaim beneficial ownership except for pecuniary interest. The comments state each reporting person disclaims beneficial ownership except to the extent of their pecuniary interest, per the signature block language.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Nutex Health, Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

67079U306

(CUSIP Number)

05/01/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 67079U306

1

Names of Reporting Persons

Pertento Partners LLP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 405,029.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 405,029.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

405,029.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.9 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 67079U306

1

Names of Reporting Persons

Pertento Advisors LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 405,029.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 405,029.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

405,029.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.9 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 67079U306

1

Names of Reporting Persons

Pertento Master Fund Limited

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 361,201.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 361,201.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

361,201.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.3 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 67079U306

1

Names of Reporting Persons

Eduardo Marques

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

BRAZIL

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 405,029.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 405,029.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

405,029.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.9 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Nutex Health, Inc.
(b)	Address of issuer's principal executive offices: 1776 Yorktown St., Suite 700, Houston, Texas 77056
Item 2.
(a)	Name of person filing: Pertento Partners LLP Pertento Advisors LLC Pertento Master Fund Limited Eduardo Marques
(b)	Address or principal business office or, if none, residence: Pertento Partners LLP 111 Park Street London W1K7JL United Kingdom Pertento Advisors LLC 111 Park Street London W1K7JL United Kingdom Pertento Master Fund Limited 111 Park Street London W1K7JL United Kingdom Eduardo Marques 111 Park Street London W1K7JL United Kingdom
(c)	Citizenship: Pertento Partners LLP - United Kingdom Pertento Advisors LLC - Delaware Pertento Master Fund Limited - Cayman Islands Eduardo Marques - Brazil
(d)	Title of class of securities: Common Stock, $0.001 par value
(e)	CUSIP No.: 67079U306
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Pertento Partners LLP - 405,029 Pertento Advisors LLC - 405,029 Pertento Master Fund Limited - 361,201 Eduardo Marques - 405,029
(b)	Percent of class: Pertento Partners LLP - 5.9% Pertento Advisors LLC - 5.9% Pertento Master Fund Limited - 5.3% Eduardo Marques - 5.9%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Pertento Partners LLP - 405,029 Pertento Advisors LLC - 405,029 Pertento Master Fund Limited - 361,201 Eduardo Marques - 405,029
	(ii) Shared power to vote or to direct the vote: Pertento Partners LLP - 0 Pertento Advisors LLC - 0 Pertento Master Fund Limited - 0 Eduardo Marques - 0
	(iii) Sole power to dispose or to direct the disposition of: Pertento Partners LLP - 405,029 Pertento Advisors LLC - 405,029 Pertento Master Fund Limited - 361,201 Eduardo Marques - 405,029
	(iv) Shared power to dispose or to direct the disposition of: Pertento Partners LLP - 405,029 Pertento Advisors LLC - 405,029 Pertento Master Fund Limited - 361,201 Eduardo Marques - 405,029
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. All of the securities reported in this Schedule 13G amendment are directly owned by advisory clients of Pertento Partners LLP. None of those advisory clients, other than Pertento Master Fund Limited, may be deemed to beneficially own more than 5% of the Common Stock, $0.01 par value.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Pertento Partners LLP

Signature:	/s/ Eduardo Marques
Name/Title:	Eduardo Marques, Managing Partner
Date:	05/07/2026

Pertento Advisors LLC

Signature:	/s/ Eduardo Marques
Name/Title:	Eduardo Marques, Authorized Person
Date:	05/07/2026

Pertento Master Fund Limited

Signature:	/s/ Eduardo Marques
Name/Title:	Eduardo Marques, Authorized Person
Date:	05/07/2026

Eduardo Marques

Signature:	/s/ Eduardo Marques
Name/Title:	Eduardo Marques
Date:	05/07/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.

Exhibit Information

Exhibit A - Joint Filing Agreement